Heron Therapeutics
HRTX
HRTX
164 hedge funds and large institutions have $274M invested in Heron Therapeutics in 2025 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 50 increasing their positions, 46 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 161 → 164 (+3)
9% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 46
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
164
Holding in Top 10
3
Calls
$4.21M
Puts
$171K
Top Buyers
| 1 | +$6.51M | |
| 2 | +$6.11M | |
| 3 | +$3.74M | |
| 4 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
+$2.99M |
| 5 |
Millennium Management
New York
|
+$2.6M |
Top Sellers
| 1 | -$1.89M | |
| 2 | -$1.65M | |
| 3 | -$1.62M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.43M |
| 5 |
OCM
Orchard Capital Management
Chicago,
Illinois
|
-$978K |